Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy clinical trials

Explore recruiting hematopoietic stem cell transplant associated thrombotic microangiopathy clinical trials.

Recruiting hematopoietic stem cell transplant associated thrombotic microangiopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Ravulizumab in Adult and Adolescent Participants who have Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplant (HSCT)

Germany, Poland, France, Spain, Sweden, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (from 1 month to <18 years of age) with Thrombotic Microangiopathy (TMA) after Hematopoietic Stem Cell Transplantation (HSCT)

Spain, France, Germany, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy trials by city

Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Toronto Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Vancouver Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Montreal Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Calgary Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Edmonton Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Ottawa Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Winnipeg Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Quebec City Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Hamilton Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Kitchener Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in London Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Halifax Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in New York Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Los Angeles Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Chicago Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease